Compare LAMR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAMR | SNN |
|---|---|---|
| Founded | 1902 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 14.3B |
| IPO Year | 1999 | N/A |
| Metric | LAMR | SNN |
|---|---|---|
| Price | $153.03 | $30.59 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $136.00 | $36.25 |
| AVG Volume (30 Days) | 680.9K | ★ 1.3M |
| Earning Date | 05-07-2026 | 03-16-2026 |
| Dividend Yield | ★ 4.74% | 2.48% |
| EPS Growth | ★ 63.92 | N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.47 | $8.58 |
| Revenue Next Year | $3.77 | $5.60 |
| P/E Ratio | $152.61 | ★ $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $113.66 | $28.40 |
| 52 Week High | $158.69 | $38.79 |
| Indicator | LAMR | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 66.60 | 45.77 |
| Support Level | $123.78 | $29.08 |
| Resistance Level | $158.69 | $33.89 |
| Average True Range (ATR) | 4.31 | 0.55 |
| MACD | 0.30 | 0.17 |
| Stochastic Oscillator | 73.15 | 58.47 |
Lamar Advertising Co is an outdoor advertising company that operates as a real estate investment trust. It is engaged in the outdoor advertising business, operating outdoor advertising displays and logo signs mainly near highway exits, delivering brand-name information on available gas, food, lodging, and camping services. Included in the company's logo sign business are tourism signing contracts. It also provides transit advertising services in airport terminals, on bus shelters, benches, and buses. The company manages its operations through three operating segments: Billboard, which generates maximum revenue, Logo, and Transit Advertising. Geographically, it operates in the United States and Canada.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.